Scattered genomic amplification in dedifferentiated liposarcoma

[1]  T. Lange,et al.  Telomeres in cancer: tumour suppression and genome instability , 2017, Nature Reviews Molecular Cell Biology.

[2]  Martin L. Miller,et al.  Integrin-α10 Dependency Identifies RAC and RICTOR as Therapeutic Targets in High-Grade Myxofibrosarcoma. , 2016, Cancer discovery.

[3]  Peter Lichter,et al.  Chromothripsis in cancer cells: An update , 2016, International journal of cancer.

[4]  Z. Storchová,et al.  Effects of aneuploidy on gene expression: implications for cancer , 2016, The FEBS journal.

[5]  D. Gisselsson,et al.  Genetic heterogeneity in rhabdomyosarcoma revealed by SNP array analysis , 2016, Genes, chromosomes & cancer.

[6]  F. Mitelman,et al.  Cancer cytogenetics: Fourth edition , 2015 .

[7]  Y. Jeng,et al.  Alternative lengthening of telomeres and loss of ATRX are frequent events in pleomorphic and dedifferentiated liposarcomas , 2015, Modern Pathology.

[8]  O. Larsson,et al.  RNA sequencing of sarcomas with simple karyotypes: identification and enrichment of fusion transcripts , 2015, Laboratory Investigation.

[9]  S. Gagos,et al.  Nuclear-Receptor-Mediated Telomere Insertion Leads to Genome Instability in ALT Cancers , 2015, Cell.

[10]  O. Kallioniemi,et al.  FusionCatcher – a tool for finding somatic fusion genes in paired-end RNA-sequencing data , 2014, bioRxiv.

[11]  David M. Thomas,et al.  The architecture and evolution of cancer neochromosomes. , 2014, Cancer cell.

[12]  O. Griffith,et al.  Mitelman Database (Chromosome Aberrations and Gene Fusions in Cancer) , 2014 .

[13]  F. Mertens,et al.  Integrative genome and transcriptome analyses reveal two distinct types of ring chromosome in soft tissue sarcomas. , 2014, Human molecular genetics.

[14]  Jan Koster,et al.  Prevalence and clinical implications of chromothripsis in cancer genomes , 2014, Current opinion in oncology.

[15]  R. Sciot,et al.  Fusion of the AHRR and NCOA2 genes through a recurrent translocation t(5;8)(p15;q13) in soft tissue angiofibroma results in upregulation of aryl hydrocarbon receptor target genes , 2012, Genes, chromosomes & cancer.

[16]  Wen-Ren Wu,et al.  Characterization of Gene Amplification–Driven SKP2 Overexpression in Myxofibrosarcoma: Potential Implications in Tumor Progression and Therapeutics , 2012, Clinical Cancer Research.

[17]  F. Chibon,et al.  From PTEN loss of expression to RICTOR role in smooth muscle differentiation: complex involvement of the mTOR pathway in leiomyosarcomas and pleomorphic sarcomas , 2012, Modern Pathology.

[18]  Anders Isaksson,et al.  Allele-specific copy number analysis of tumor samples with aneuploidy and tumor heterogeneity , 2011, Genome Biology.

[19]  S. Dry,et al.  Evaluation of well‐differentiated/de‐differentiated liposarcomas by high‐resolution oligonucleotide array‐based comparative genomic hybridization , 2011, Genes, chromosomes & cancer.

[20]  G. Morgan,et al.  Heterogeneity in the prognostic significance of 12p deletion and chromosome 5 amplification in multiple myeloma. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  F. Chibon,et al.  New insights in sarcoma oncogenesis: a comprehensive analysis of a large series of 160 soft tissue sarcomas with complex genomics , 2011, The Journal of pathology.

[22]  R. Hochstenbach,et al.  Telomere healing following DNA polymerase arrest‐induced breakages is likely the main mechanism generating chromosome 4p terminal deletions , 2010, Human mutation.

[23]  Derek Y. Chiang,et al.  Subtype-specific genomic alterations define new targets for soft tissue sarcoma therapy , 2010, Nature Genetics.

[24]  L. Guillou,et al.  Soft tissue sarcomas with complex genomic profiles , 2010, Virchows Archiv.

[25]  S. Devries,et al.  Similarity in genetic alterations between paired well-differentiated and dedifferentiated components of dedifferentiated liposarcoma , 2009, Modern Pathology.

[26]  M. Loda,et al.  c‐Jun amplification and overexpression are oncogenic in liposarcoma but not always sufficient to inhibit the adipocytic differentiation programme , 2009, The Journal of pathology.

[27]  S. Knuutila,et al.  Does comparative genomic hybridization reveal distinct differences in DNA copy number sequence patterns between leiomyosarcoma and malignant fibrous histiocytoma? , 2008, Cancer genetics and cytogenetics.

[28]  M. Mansukhani,et al.  Integrative genomics analysis of chromosome 5p gain in cervical cancer reveals target over-expressed genes, including Drosha , 2008, Molecular Cancer.

[29]  Jin Man Kim,et al.  Gain at chromosomal region 5p15.33, containing TERT, is the most frequent genetic event in early stages of non-small cell lung cancer. , 2008, Cancer genetics and cytogenetics.

[30]  P. Lichter,et al.  Frequent amplifications and abundant expression of TRIO, NKD2, and IRX2 in soft tissue sarcomas , 2006, Genes, chromosomes & cancer.

[31]  Y. Korogi,et al.  Cytogenetic analysis of myxoid liposarcoma and myxofibrosarcoma by array-based comparative genomic hybridisation , 2006, Journal of Clinical Pathology.

[32]  H. Taubert,et al.  Gains of 13q are correlated with a poor prognosis in liposarcoma , 2005, Modern Pathology.

[33]  F. Mertens,et al.  Atypical lipomatous tumor with rare structural rearrangements involving chromosomes 8 and 12. , 2005, Oncology reports.

[34]  O. Mariani,et al.  Myxoid malignant fibrous histiocytoma and pleomorphic liposarcoma share very similar genomic imbalances , 2005, Laboratory Investigation.

[35]  G. Sauter,et al.  TRIO amplification and abundant mRNA expression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancer. , 2004, The American journal of pathology.

[36]  Yong-jie Lu,et al.  Loss of 13q14-q21 and Gain of 5p14-pter in the Progression of Leiomyosarcoma , 2003, Modern Pathology.

[37]  O. Mariani,et al.  A subgroup of malignant fibrous histiocytomas is associated with genetic changes similar to those of well-differentiated liposarcomas. , 2002, Cancer genetics and cytogenetics.

[38]  B. Bjerkehagen,et al.  Characterization of supernumerary rings and giant marker chromosomes in well-differentiated lipomatous tumors by a combination of G-banding, CGH, M-FISH, and chromosome- and locus-specific FISH , 2002, Cytogenetic and Genome Research.

[39]  O. Myklebost,et al.  A well-differentiated liposarcoma with a new type of chromosome 12-derived markers. , 2001, Cancer genetics and cytogenetics.

[40]  D. Nižetić,et al.  Ectopic sequences from truncated HMGIC in liposarcomas are derived from various amplified chromosomal regions , 2001, Genes, chromosomes & cancer.

[41]  D. Gisselsson,et al.  Chromosomal breakage-fusion-bridge events cause genetic intratumor heterogeneity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[42]  F. Collin,et al.  Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors , 1999, Genes, chromosomes & cancer.

[43]  C. Fletcher,et al.  Soft Tissue Tumors , 1995, Current Topics in Pathology.

[44]  S. Knuutila,et al.  Gains and losses of DNA sequences in liposarcomas evaluated by comparative genomic hybridization , 1996, Genes, chromosomes & cancer.

[45]  F. Mitelman,et al.  Three major cytogenetic subgroups can be identified among chromosomally abnormal solitary lipomas , 1988, Human Genetics.

[46]  F. Mitelman,et al.  Mitelman database of chromosome aberrations and gene fusions in cancer , 2014 .

[47]  M. Stratton,et al.  A census of amplified and overexpressed human cancer genes , 2010, Nature Reviews Cancer.